Incorporating environmental, social, and corporate governance considerations into the investment decision-making processes to create value for our investors and to develop a more sustainable long‐term strategy.

NovaQuest is committed to incorporating consideration of Environmental, Social and Governance (ESG) factors in our investment decision-making process. In addition to being in line with our “One Health” philosophy, we believe that incorporating ESG considerations creates value for our investors by mitigating undue risk and emphasizing long-term sustainability and resilience in our investment portfolio.
To this end, NovaQuest has developed an ESG Policy that outlines our approach to integration and consideration of ESG factors in our investment processes.
The ESG Policy outlines a standard process of ESG diligence and investment decision-making for all product finance and equity investments being contemplated by NovaQuest’s Investment Committees. The diligence process is informed by industry-specific guidance including the Sustainability Accounting Standards Board (SASB)’s Biotechnology and Pharmaceuticals Standard, and the Biopharma Investor ESG Communications Guidance 2.0.
The ESG Policy also outlines procedures for engagement and monitoring of ESG-related matters across the portfolio, subject to limitations that may be posed by virtue of NovaQuest’s role in a given transaction.
Through implementation of this ESG Policy, NovaQuest aims to minimize exposure to ESG-related risks and to encourage improvements in ESG performance over time where our position allows us to do so.

The information being provided is strictly as a courtesy. When you link to any of the websites provided here, you are leaving this website. We make no representation as to the completeness or accuracy of information provided at these websites, nor do we assume any risk of using such websites.

Proceed to Link